Volpatti Lab publishes a manuscript in Cell Biomaterials "PEG-lipid shedding and biodistribution are shaped by nanocarrier morphology and lipid chemistry" (March 2026)
Volpatti Lab publishes a manuscript in Nature Biomedical Engineering "LDL-binding IL-10 reduces vascular inflammation in atherosclerotic mice" (January 2026)
Dr. Volpatti is co-corresponding author on a manuscript published in JCI Insight "A prometabolite strategy inhibits cardiometabolic disease in an ApoE-/- murine model of atherosclerosis" (August 2025)
Dr. Volpatti receives a Hartwell Individual Biomedical Research Award (April 2025)
Dr. Volpatti receives a PhRMA Foundation Faculty Starter Grant in Drug Delivery (February 2025)
Lab doors officially open (October 2024) 🎉
K22 Phase II awarded (July 2024)
Dr. Volpatti is named a Chan Zuckerberg Biohub Chicago Investigator (April 2024)